Skip to content
Screener

NeoGenomics NEO Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$7.1M-34.9%
Labcorp Holdings logo
Labcorp HoldingsLH
$180.3M-3.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$180M+5.3%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$1.61M+30.6%
Personalis, Inc. logo
Personalis, Inc.PSNL
$6.88M-7.9%
Guardant Health logo
Guardant HealthGH
$28.03M-5.5%

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2.13B+183%
Enterprise value$2.43B+264%
P/S2.8×+1.7×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line item(unaudited)June 30, 2026December 31, 2025
Accounts payable$20,953$23,090
Accrued compensation56,26547,580
Accrued expenses and other liabilities23,04511,975
Current portion of operating lease liabilities3,7224,776
Current portion of finance lease liabilities1,70428
Contract liabilities194851
Total current liabilities105,88388,300
Long-term liabilities

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's operating lease liabilities (current)?
NeoGenomics (NEO) reported operating lease liabilities (current) of $3.72M in Q2 2026.
How has NeoGenomics's operating lease liabilities (current) changed year-over-year?
NeoGenomics's operating lease liabilities (current) decreased by 8.1% year-over-year, from $4.05M to $3.72M.
What is the long-term trend for NeoGenomics's operating lease liabilities (current)?
Over 5 years (2020 to 2025), NeoGenomics's operating lease liabilities (current) has grown at a -0.8% compound annual growth rate (CAGR), from $4.97M to $4.78M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about NeoGenomics's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude